Market Overview

The Enteric Softgel Capsules Market is experiencing steady growth, driven by Increasing Demand for Targeted Drug Delivery, Growing Popularity of Nutraceuticals and Dietary Supplements and Rising Pharmaceutical R&D and Drug Approvals. According to IMARC Group’s latest research publication, “Enteric Softgel Capsules Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025–2033”, The global enteric softgel capsules market size reached USD 2.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.7 Billion by 2033, exhibiting a growth rate (CAGR) of 3.6% during 2025-2033.

This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers  and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis.

Grab a sample PDF of this report: https://www.imarcgroup.com/enteric-softgel-capsules-market/requestsample

Our Report Includes:

• Market Dynamics
• Market Trends and Outlook
• Competitive Landscape Analysis
• Industry Segmentation
• Strategic Recommendations

Growth Factors in the Enteric Softgel Capsules Industry

• Increasing Demand for Targeted Drug Delivery

Enteric softgel capsules are gaining traction as an advanced oral dosage form that enables site-specific drug release. By resisting degradation in the stomach and dissolving only in the intestine, these capsules provide higher bioavailability and therapeutic precision. This makes them especially useful for drugs that are unstable in gastric acid or require localized intestinal absorption. Rising prevalence of gastrointestinal disorders, such as Crohn’s disease and ulcerative colitis, is further driving adoption. Beyond pharmaceuticals, nutraceutical companies are increasingly adopting enteric softgels for probiotics, enzymes, and fish oils to enhance absorption and minimize gastric discomfort. The need for effective delivery systems that improve compliance and clinical outcomes continues to fuel strong demand globally.

• Growing Popularity of Nutraceuticals and Dietary Supplements

Preventive healthcare and wellness trends are significantly boosting the consumption of nutraceuticals delivered through enteric-coated capsules. Consumers are seeking products that offer enhanced absorption and avoid common issues such as reflux or aftertaste. Popular supplement categories include omega-3 fatty acids, curcumin, herbal extracts, and live probiotics, all of which benefit from enteric protection. This format not only ensures stability during digestion but also improves consumer trust in supplement efficacy. Online retail channels and subscription-based models are expanding access to these products worldwide. With rising awareness about immunity, digestive health, and cognitive well-being, enteric softgels are becoming the preferred choice for supplement manufacturers aiming to differentiate their offerings.

• Rising Pharmaceutical R&D and Drug Approvals

Pharmaceutical innovation is a major growth driver for enteric softgel capsules. The development of oral biologics, peptides, and other acid-sensitive molecules requires specialized encapsulation for effective delivery. Regulatory agencies are approving a growing number of drugs formulated with enteric protection, underscoring their clinical relevance. Advances in capsule technologies—such as multifunctional polymers, dual-layer coatings, and controlled-release systems—are enabling precise dosing and reduced side effects. Furthermore, partnerships between pharma companies and capsule technology providers are fostering novel applications in therapeutic areas including oncology, gastrointestinal diseases, and central nervous system disorders. As R&D pipelines expand, enteric softgels are poised to capture a larger share of the oral drug delivery market.

Key Trends in the Enteric Softgel Capsules Market

• Shift Toward Plant-Based and Gelatin Alternatives

Consumer demand for vegan, vegetarian, and allergen-free solutions is reshaping capsule production. Traditional gelatin-based capsules are being replaced with plant-derived polymers, starches, and modified cellulose to align with ethical and cultural preferences. This shift is strongest in Western markets, where clean-label claims drive purchasing behavior. Plant-based enteric softgels not only meet consumer expectations but also support sustainability initiatives by reducing reliance on animal byproducts. Nutraceutical brands in particular are adopting vegetarian capsules to appeal to millennials and health-conscious consumers. The growing demand for transparent, eco-friendly formulations is expected to accelerate adoption of plant-based enteric capsule technologies worldwide.

• Integration of Advanced Polymers and Coating Technologies

Continuous innovation in excipients and coating methods is enhancing the performance of enteric capsules. Next-generation pH-sensitive polymers enable precise release at targeted intestinal sites, improving both efficacy and patient experience. Water-based and solvent-free coating technologies are being adopted to reduce environmental impact and improve manufacturing efficiency. Additionally, research into nanotechnology and 3D printing is opening new possibilities for personalized drug delivery systems. Coatings that combine multiple functions—such as delayed release, taste-masking, and improved stability—are becoming increasingly popular. With pharmaceutical companies demanding higher precision and flexibility, advanced coating technologies are emerging as a critical differentiator in the competitive market.

• Expansion of Contract Manufacturing and Outsourcing

Outsourcing remains a defining trend in the enteric softgel market, as pharmaceutical and nutraceutical companies seek cost-effective, scalable solutions. Contract Development and Manufacturing Organizations (CDMOs) provide specialized expertise, regulatory support, and advanced production facilities that many companies lack in-house. This model allows brands to accelerate product launches while focusing on core R&D and marketing strategies. Asia-Pacific, particularly India and China, has become a hub for large-scale capsule production due to lower costs and skilled labor availability. Global players are increasingly partnering with these regional manufacturers to meet rising demand. The growth of outsourcing is expanding capacity, fostering innovation, and creating a more competitive marketplace for enteric capsule solutions.

We explore the factors propelling the enteric softgel capsules market growth, including technological advancements, consumer behaviors, and regulatory changes.

Leading Companies Operating in the Global Enteric Softgel Capsules Industry:

• Aenova Group GmbH
• BASF SE
• Catalent, Inc.
• Colorcon Inc.
• Fuji Capsule Co., Ltd.
• Lonza Group AG
• Now Health Group, Inc.
• ProCaps Group
• Super Spectrim
• Thermo Fisher Scientific, Inc

Enteric Softgel Capsules Market Report Segmentation:

By Type:

• Gelatin Capsules
• Non-Gelatin Softgel Capsules

Gelatin capsules represent the largest segment as they can be easily consumed and offer spontaneous absorption.

By Application:

• Health Supplements
• Pharmaceuticals

Health supplements exhibit a clear dominance in the market due to the rising health awareness among the masses.

By Distribution Channel:

• Supermarkets and Hypermarkets
• Pharmacy and Drug Stores
• Online Stores

Pharmacy and drug stores represent the leading segment. They offer an extensive range of enteric softgel capsules for a reasonable price range.

Regional Insights:

• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

North America’s dominance in the enteric softgel capsules market is attributed to investment in drug research, leading to the development of advanced medications.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1–201971–6302